Chao Tze-Fan, Joung Boyoung, Takahashi Yoshihide, Lim Toon Wei, Choi Eue-Keun, Chan Yi-Hsin, Guo Yutao, Sriratanasathavorn Charn, Oh Seil, Okumura Ken, Lip Gregory Y H
Division of Cardiology Department of Medicine Taipei Veterans General Hospital Taipei Taiwan.
Institute of Clinical Medicine, and Cardiovascular Research Center National Yang Ming Chiao Tung University Taipei Taiwan.
J Arrhythm. 2021 Nov 13;37(6):1389-1426. doi: 10.1002/joa3.12652. eCollection 2021 Dec.
The consensus of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation (AF) has been published in 2017 which provided useful clinical guidance for cardiologists, neurologists, geriatricians, and general practitioners in Asia-Pacific region. In these years, many important new data regarding stroke prevention in AF were reported. The Practice Guidelines subcommittee members comprehensively reviewed updated information on stroke prevention in AF, and summarized them in this 2021 focused update of the 2017 consensus guidelines of the APHRS on stroke prevention in AF. We highlighted and focused on several issues, including the importance of AF Better Care (ABC) pathway, the advantages of non-vitamin K antagonist oral anticoagulants (NOACs) for Asians, the considerations of use of NOACs for Asian patients with AF with single 1 stroke risk factor beyond gender, the role of lifestyle factors on stroke risk, the use of oral anticoagulants during the "coronavirus disease 2019" (COVID-19) pandemic, etc. We fully realize that there are gaps, unaddressed questions, and many areas of uncertainty and debate in the current knowledge of AF, and the physician's decision remains the most important factor in the management of AF.
亚太心律学会(APHRS)关于心房颤动(AF)卒中预防的共识已于2017年发表,为亚太地区的心脏病专家、神经科医生、老年病医生和全科医生提供了有用的临床指导。近年来,报告了许多关于AF卒中预防的重要新数据。实践指南小组委员会成员全面审查了AF卒中预防的最新信息,并将其总结在这份2021年APHRS关于AF卒中预防的2017年共识指南重点更新中。我们突出并关注了几个问题,包括AF更好管理(ABC)路径的重要性、非维生素K拮抗剂口服抗凝剂(NOACs)对亚洲人的优势、对具有除性别外单一卒中风险因素的亚洲AF患者使用NOACs的考量、生活方式因素对卒中风险的作用、在2019冠状病毒病(COVID-19)大流行期间口服抗凝剂的使用等。我们充分认识到,在目前关于AF的知识中存在差距、未解决的问题以及许多不确定和有争议的领域,而医生的决策仍然是AF管理中最重要的因素。